Tuberculosis News and Research

Latest Tuberculosis News and Research

WHO study names top pathogens in need of new vaccines

A new World Health Organization (WHO) study published today in eBioMedicine names 17 pathogens that regularly cause diseases in communities as top priorities for new vaccine development.

5 Nov 2024

Study finds high risk of pediatric tuberculosis in high-burden areas

New findings also indicate that children who live in settings with a high burden of TB have a consistently high annual risk of developing TB infection throughout childhood.

5 Nov 2024

WHO reports alarming rise in tuberculosis cases in 2023

The World Health Organization (WHO) today published a new report on tuberculosis revealing that approximately 8.2 million people were newly diagnosed with TB in 2023 – the highest number recorded since WHO began global TB monitoring in 1995.

29 Oct 2024

Researchers decode MRSA biofilm structure to combat antibiotic resistance

Imagine falling seriously ill with an infection. Normally, we visit the doctor, are prescribed antibiotics, and after 7-10 days, we're back on our feet.

24 Oct 2024

New smell technology may open doors for medical diagnostics

Although smell has historically played an important role in the fight against diseases such as the plague and tuberculosis, the human nose is generally not sensitive enough to be used as a reliable diagnostic tool.

21 Oct 2024

Report outlines path to halve premature deaths by 2050

Since 1970, 37 countries have cut the probability of their citizens dying before they reach age 70 in half, a milestone that signals the remarkable progress many countries have made in preventing and treating disease.

14 Oct 2024

Researchers uncover mechanism of protein GBP1 in immune defense

The protein GBP1 is a vital component of our body's natural defence against pathogens. This substance fights against bacteria and parasites by enveloping them in a protein coat, but how the substance manages to do this has remained unknown until now.

12 Oct 2024

Harnessing neural networks to forecast treatment outcomes in small cell lung cancer

As immunotherapy makes breakthrough progress in the treatment of small cell lung cancer (SCLC), predicting treatment outcomes has become a focal point in clinical practice. Immunotherapy combined with chemotherapy has been approved as first-line therapy for small cell lung cancer due to its survival benefit in randomized controlled trials.

12 Oct 2024

New study reveals unique metabolic function of lung-resident NK immune cells

Trinity College Dublin researchers, based at St James's Hospital have provided important insights into the behavior and metabolic function of a previously largely unknown, but crucial 'natural killer' (NK) immune cell resident in the lungs.

12 Oct 2024

New cell culture model sheds light on immune protein's role in infectious diseases

A human cell culture model of the lung's most important immune cells, alveolar macrophages, helped make a key finding that is prompting researchers to rethink the role of another immune protein in infectious disease.

10 Oct 2024

WHO report highlights the role of vaccines in reducing antibiotic use

A new report by the World Health Organization (WHO) finds that vaccines against 24 pathogens could reduce the number of antibiotics needed by 22% or 2.5 billion defined daily doses globally every year, supporting worldwide efforts to address antimicrobial resistance (AMR).

10 Oct 2024

Happening in Springfield: New immigrants offer economic promise, health system challenges

When Republican vice presidential candidate JD Vance claimed Haitian immigrants had caused infectious-disease rates to "skyrocket" in Springfield, Ohio, local health commissioner Chris Cook checked the records.

10 Oct 2024

Modified bloodroot compound shows promise against multidrug-resistant tuberculosis

A modified compound taken from bloodroot, a wildflower native to North America, effectively fights multidrug-resistant tuberculosis (TB) bacteria in the test tube, according to a new study.

8 Oct 2024

UMass Amherst researcher receives $2.2 million grant to study tuberculosis response

The National Institutes of Health recently awarded $2.2 million to Alissa Rothchild, assistant professor in the Department of Veterinary and Animal Sciences at the University of Massachusetts Amherst and an expert in tuberculosis (TB) immunology, to study the very first cells that respond to Mycobacterium tuberculosis (Mtb), the bacteria causing TB.

7 Oct 2024

Novel semi-synthetic compound shows promise against drug-resistant tuberculosis

A new study published in the American Society for Microbiology journal Microbiology Spectrum demonstrates that a novel semi-synthetic compound can be derived from natural compounds to produce potent activity against Mycobacterium tuberculosis, including multi-drug resistant strains.

3 Oct 2024

Scientists identify gut microbial signatures that distinguish diseases and predict health states

Study reveals significant gut microbial differences across diseases in the Chinese population, identifying universal microbial signatures that could predict disease states with high accuracy.

2 Oct 2024

New mechanism uncovered behind immune decline after tuberculosis treatment

Researchers at Baylor College of Medicine and collaborating institutions have discovered a mechanism that drives the long-term decline in immune response that is observed after tuberculosis (TB) has been successfully treated.

1 Oct 2024

Macrophage memory following COVID infection provides cross-virus protection

More than 200 viruses can infect and cause disease in humans; most of us will be infected by several over the course of a lifetime.

30 Sep 2024

New breath-based test for lower respiratory tract infections shows 100% sensitivity in critical care settings

Researchers have developed a breath-based in vitro assay that accurately detects lower respiratory tract infections (LRTIs) by measuring neutrophil elastase activity. This non-invasive test offers high diagnostic sensitivity and could revolutionize LRTI detection.

29 Sep 2024

Global leaders unite to tackle drug-resistant bacteria

World leaders meeting in New York have backed a new set of goals and pledged to find US$100 million in funding to address the problem of drug-resistant bacteria, a global crisis that is all the more acute in the poorest countries.

27 Sep 2024